West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
269,50 € ↑3,00 (1,13%)
2026-06-04
AKTIENPREIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionJohnson Financial Group, Inc.
Latest Disclosed Ownership16 shares
Latest Disclosed Value $ 4,011
Johnson Financial Group, Inc. reports 23.81% decrease in ownership of WPS / West Pharmaceutical Services, Inc.

On May 7, 2026 - Johnson Financial Group, Inc. filed a 13F-HR form disclosing ownership of 16 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $3,416 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 21 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -23.81% during the quarter. The current value of the position is $4,312 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 16 -5 -23.81 4 -20.00 0.0001
2026-02-12 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 21 -58 -73.42 6 -75.00 0.0002
2025-11-13 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 79 79 21 0.0008
2025-08-13 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -138 -100.00 0 -100.00
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 138 127 1,154.55 31 900.00 0.0015
2025-02-14 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 11 -16 -59.26 4 -62.50 0.0002
2024-11-13 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 27 27 8 0.0004
2019-05-13 2019-03-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 0 -28 -100.00 0 -100.00
2019-02-11 2018-12-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 28 0 0.00 3 0.00 0.0003
2018-11-09 2018-09-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 28 0 0.00 3 0.00 0.0003
2018-08-07 2018-06-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 28 28 3 0.0003
2017-02-07 2016-12-31 13F/A-1 WEST PHARMACEUTICAL SVCS COM 955306105 0 0 0 0.0000
2016-11-14 2016-09-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 0 -500 -100.00 0 -100.00
2016-08-12 2016-06-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 500 237 90.11 38 100.00 0.0053
2016-05-09 2016-03-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 263 -295 -52.87 19 -42.42 0.0038
2016-02-08 2015-12-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 558 -2,392 -81.08 33 -79.37 0.0069
2015-11-02 2015-09-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 2,950 0 0.00 160 -6.43 0.0350
2015-08-11 2015-06-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 2,950 -975 -24.84 171 -27.54 0.0354
2015-05-12 2015-03-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 3,925 -325 -7.65 236 4.42 0.0507
2015-02-10 2014-12-31 13F WEST PHARMACEUTICAL SVCS COM 955306105 4,250 -350 -7.61 226 9.71 0.0524
2014-11-14 2014-09-30 13F WEST PHARMACEUTICAL SVCS COM 955306105 4,600 25 0.55 206 6.74 0.0537
2014-08-06 2014-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,575 3,100 210.17 193 196.92 0.0509
2014-05-14 2014-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,475 0 0.00 65 -9.72 0.0190
2014-02-11 2013-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,475 -1,150 -43.81 72 -33.33 0.0208
2013-11-14 2013-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,625 -350 -11.76 108 -48.33 0.0328
2013-08-14 2013-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,975 2,975 209 0.0582
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.